Pathways associated with inflammation are thought to account for increased vascular risk in patients with chronic inflammatory diseases. This Review summarizes key epidemiologic, physiologic and model data that implicate involvement of tumor necrosis factor, a pivotal cytokine in the inflammatory cascade, in atherosclerosis.
- Gayle E. McKellar
- David W. McCarey
- Iain B. McInnes